Physician profile
Geetha Bhat
NPI 1841290244
$3,576.59
in general payments reported to CMS, 2019-2025
11 companies · $615 in 2025
The $615 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $794 · 2023: $703 · 2024: $1,465 · 2025: $615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,619 · Food and Beverage: $1,163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,619.35 |
| Food and Beverage | $1,163.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Transmedics, INC. | $1,619.35 | 2023-2025 | Organ Care System |
| Abbott Laboratories | $841.56 | 2022-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Thoratec Heartmate II, Lvas Implant Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $295.01 | 2022-2023 | Lifevest |
| Briohealth Solutions, INC. | $148.49 | 2025 | Briovad |
| La Jolla Pharmaceutical Company | $143.65 | 2025 | Giapreza |
| E.R. Squibb & Sons, L.L.C. | $126.32 | 2022 | |
| Amgen INC. | $124.03 | 2025 | Krystexxa |
| Sanofi-Aventis U.S. LLC | $119.73 | 2025 | |
| Philips North America LLC | $88.99 | 2024 | (Ck4) Mcot |
| Abiomed | $46.46 | 2024 | Impella |
| One Lambda, INC. | $23.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geetha Bhat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.